Immatics NV (IMTX)
7.43
+0.06
(+0.81%)
USD |
NASDAQ |
Oct 09, 16:00
7.42
-0.01
(-0.13%)
After-Hours: 20:00
Immatics Free Cash Flow : -246.23M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -246.23M |
| March 31, 2026 | -224.28M |
| December 31, 2025 | -213.50M |
| September 30, 2025 | -205.19M |
| June 30, 2025 | -190.78M |
| March 31, 2025 | -180.10M |
| December 31, 2024 | -186.15M |
| September 30, 2024 | -49.49M |
| June 30, 2024 | -47.92M |
| March 31, 2024 | -28.95M |
| December 31, 2023 | -13.69M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 119.10M |
| March 31, 2022 | 41.94M |
| December 31, 2021 | -99.91M |
| September 30, 2021 | -103.54M |
| June 30, 2021 | -139.94M |
| March 31, 2021 | -97.95M |
| December 31, 2020 | -110.99M |
| September 30, 2020 | -49.50M |
| June 30, 2020 | 61.88M |
| March 31, 2020 | 39.73M |
| December 31, 2019 | 72.86M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioNTech SE | 424.34M |
| MediGene AG | -- |
| InflaRx NV | -32.78M |
| Twist Bioscience Corp. | -93.22M |
| Prime Medicine, Inc. | -156.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.00M |
| Cash from Investing (Quarterly) | -9.277M |
| Cash from Financing (Quarterly) | -0.9257M |
| Free Cash Flow Per Share (Quarterly) | -0.5195 |
| Free Cash Flow to Equity (Quarterly) | -70.32M |
| Free Cash Flow to Firm (Quarterly) | -70.77M |
| Free Cash Flow Yield | -25.54% |